News
COVID-19 Vaccines May Need Updation For Omicron- WHO Body
The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be...
News
Cystic Fibrosis Treatment Approved By European Commission
When it comes to cystic fibrosis, which is a debilitating and progressive condition found in around 11000 people in the UK, no cure has...
News
Oxford Join Consortium For Advance Quantum Drug Discovery
SEEQC, which is a digital quantum computing company, and Oxford University have partnered to ensure accelerated use of computing based on the quantum method...
News
Leading Pulmonologists in India have started using Molnupiravir for mild COVID-19 cases; consider it the best bet for early treatment of COVID-19
With questions being raised on the safety of the only available approved oral antiviral pill for COVID-19 - Molnupiravir, health experts of the country have...
Clinical Trials
Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2, including Omicron
Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug candidate maintains a potent activity in neutralization assays. Recent...
News
Symbiosis announces expansion of capabilities with BSL-2 manufacturing upgrade
Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, has announced an expansion of...
Packaging & Labelling
Catalent Increases Specialized Packaging Capabilities at its Philadelphia Facility to Support Growing Biologic and Cell and Gene Therapy Market
Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















